Search company, investor...

Spirus Medical

Founded Year



Acquired | Acquired

Total Raised




About Spirus Medical

Spirus Medical has developed a new medical device for use in the diagnosis and treatment of gastrointestinal (GI) disorders. Spirus Medical's endoluminal platform technology has indications in other medical applications including urology and gynecology.In July 2011, Spirus Medical was acquired by Olympus Corporation. The valuation of Spirus Medical was $60 million. Other terms of the deal were not released.

Headquarters Location

375 West Street

West Bridgewater, Massachusetts, 02379,

United States


Missing: Spirus Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Spirus Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Spirus Medical Patents

Spirus Medical has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Catheters, Implants (medicine), Medical equipment, Cardiac procedures, Interventional cardiology


Application Date


Grant Date



Related Topics

Catheters, Implants (medicine), Medical equipment, Cardiac procedures, Interventional cardiology



Spirus Medical Frequently Asked Questions (FAQ)

  • When was Spirus Medical founded?

    Spirus Medical was founded in 2005.

  • Where is Spirus Medical's headquarters?

    Spirus Medical's headquarters is located at 375 West Street, West Bridgewater.

  • What is Spirus Medical's latest funding round?

    Spirus Medical's latest funding round is Acquired.

  • How much did Spirus Medical raise?

    Spirus Medical raised a total of $15.03M.

  • Who are the investors of Spirus Medical?

    Investors of Spirus Medical include Olympus Corporation, PJC, BioVentures Investors and Village Ventures.

  • Who are Spirus Medical's competitors?

    Competitors of Spirus Medical include NeuroPace, MicroTransponder, Endologix, Calibra Medical, Sonitus Medical and 10 more.

Compare Spirus Medical to Competitors

AbbeyMoor Medical

Abbeymoor Medical is a Minnesota corporation formed to develop urological stenting devices. Abbeymoor Medical intends for its devices to advance the assessment, management, and treatment of prostatic obstruction. The company's first product, the Spanner , was approved for sale by the FDA in December 2006.


Satiety, Inc. is a medical device company focused on the development of less invasive devices for the treatment of obesity. Obesity is a global health problem, affecting 70 million people in the U.S. and 300 million worldwide, and growth of which is causing increases in obesity-related diseases such as diabetes, high blood pressure and cardiovascular disease. Obesity surgery has been shown to be the only long-term effective means of weight loss for morbidly obese patients. Satiety's first product, the TOGA System, enables physicians to perform a procedure similar to traditional restrictive obesity surgeries, but without surgical incisions. In this procedure, the TOGA System devices are inserted transorally (through the mouth) and are used to reduce the capacity of the stomach to give patients a feeling of fullness after a small meal. The procedure is intended to be safer and easier for patients to tolerate than conventional obesity surgery. Safety and effectiveness of the TOGA System are currently being evaluated in a multi-center U.S. Study and the system is not available for sale in the United States.


Gliatech provides devices for the treatment of the nervous system

Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders


Otokinetics has been formed to create and promulgate an entirely new product category in hearing aid devices.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.